| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
Vorinostat |
CTRPv2 |
pan-cancer |
AAC |
0.0041 |
0.9 |
| mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.9 |
| mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |